The Intercytex is developing several treatments. Surely they will be developing the treatments further on when treatments are available. But if not, what will they do? Develope new treatments? Concentrate to TRC? Close the company? Sell it? COULD IT BE POSSIBLE THAT THE NEW PARTNER WOULD BE OTHER “TRC COMPANY” LIKE FOLLICA OR ADERANS ETC…? In case they´ll manage to develope a good TRC treatment then there will be plenty of money for a company or two and for the share holders.
What do you think guys?
Just my thoughts,